Temazepam
Temazepam is an orally administered benzodiazepine commonly prescribed as a treatment for insomnia. It acts by enhancing the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA) on synaptic transmission through its interaction with the GABA A receptor.
Introduced in the United States in 1981, temazepam has been widely recognized for its effectiveness as a sleep aid, with more than eight million prescriptions filled annually. Despite its affiliation with the benzodiazepine family, it has not been linked with serum aminotransferase or alkaline phosphatase elevations. Additionally, clinically apparent liver injury from temazepam use has yet to be reported, making it an extremely rare occurrence, if it happens at all.
Indications and Dosage
The primary indication for temazepam is the short-term treatment of insomnia. It is commercially available in capsule form under several generic names, as well as the brand name Restoril. Dosages range from 7.5 to 30 milligrams, with the recommended initial dose for insomnia being 7.5 milligrams taken before bedtime. This dosage may be increased as required, up to a maximum of 30 milligrams.
Mechanism of Action
Temazepam's sleep-inducing effect arises from its enhancement of GABA-mediated synaptic transmission inhibition, achieved through its binding to the GABA A receptor. GABA is the principal inhibitory neurotransmitter in the central nervous system and plays a critical role in reducing neuronal excitability.
Side Effects
The most frequently encountered side effects of temazepam are dose-dependent and can include daytime drowsiness, lethargy, ataxia, dysarthria, and dizziness. While tolerance can develop towards these side effects, it can also occur towards the medication's effects on insomnia.
See Also
This article is a medical stub. You can help WikiMD by expanding it! | |
---|---|
Benzodiazipines
- Alprazolam
- Chlordiazepoxide
- Diazepam (Oral)
- Estazolam
- Flurazepam
- Lorazepam
- Midazolam
- Oxazepam
- Quazepam
- Temazepam
- Triazolam
Anticonvulsants Drugs
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD